Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
Clinical trial NCT04722575 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04722575
- Sponsor
- Fondazione Melanoma Onlus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2023-12-15
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.